Dishman Pharmaceuticals grabs license for raw material for TB drug Pooja24 Sept 2015 12:10 PM ISTDishman Pharmaceuticals and Chemicals have been entrusted with the responsibility of providing raw material for drug used resistant tuberculosis by...
Govt to look into the GVK Bio issue on alleged manipulation Pooja24 Sept 2015 11:03 AM ISTA government panel is reported to have been constituted to look into the matter of alleged manipulation of clinical trials by GVK Bio. The issue came...
Pfizer targets to be a leader in cancer drug treatment Pooja23 Sept 2015 3:45 PM ISTDrug giant Pfizer is reported to start 20 clinical trials this year and more soon after to become a drug giant in the cancer medicine space. Only...
Sun Pharma say no to drugs for prison use in US Pooja23 Sept 2015 1:20 PM ISTIndia's Sun Pharma has expressed its displeasure over the use of its drug for lethal injection in the prison in US. The company objection comes after...
Glenmark bets big on US market sales Pooja23 Sept 2015 12:55 PM ISTIndian drugmaker Glenmark Pharmaceuticals is counting its drug fortune on a strong growth in the US market, after it is set to launch a host of new...
Dr Reddy’s Laboratories enters in a patent pact with BioMarin Pharmaceutical Meghna A Singhania22 Sept 2015 11:43 AM ISTDr Reddy’s Laboratories and California-based BioMarin have entered into a smooth pact regarding the patent issue over the 100 mg oral tablets called...
Indian Pharmacist Association pitches to PM Pooja21 Sept 2015 10:41 AM ISTThe Indian Pharmacist Association has reportedly written to the Prime Minister seeking his views on allowing the association of pharmacists to...
Lilly diabetes drug slashes deaths in patients with heart risk Meghna A Singhania20 Sept 2015 1:05 PM ISTEli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack and stroke, a finding that...
Sun Pharma sells divisions of Ranbaxy to Strides Arcolab for Rs 165 crore Meghna A Singhania20 Sept 2015 12:57 PM ISTNEW DELHI: Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides...
Competition Commission clears Baxter-Baxalta deal Meghna A Singhania20 Sept 2015 12:50 PM ISTNEW DELHI: Fair trade regulator CCI has approved the proposed transfer of Baxter India's bioscience business and related assets to its wholly-owned...
Serum Institute to sell stake to private equity firms Pooja19 Sept 2015 12:02 PM ISTSerum Institute of India Lts is reportedly in talks with private equity firms (with funds in the United States and Singapore), as confirmed by a media...
Jubilant gets approval for anti-migraine drug from FDA Pooja19 Sept 2015 11:55 AM ISTUS health regulator has given its nod to Jubilant Life Sciences to market its generic version of anti-migrane tablets, zolmitriptan orally...
